The carolactam strategy is ineffective: Synthesis and biological evaluation of carolactam

Research output: Contribution to journalArticleResearchpeer review

Authors

  • Jonas Ammermann
  • Thomas Schmidt
  • Jannik Donner
  • Michael Reck
  • Marly Dalton
  • Nico Stumpp
  • Meike Stiesch
  • Irene Wagner-Döbler
  • Andreas Kirschning

External Research Organisations

  • Helmholtz Centre for Infection Research (HZI)
  • Hannover Medical School (MHH)
View graph of relations

Details

Original languageEnglish
Pages (from-to)8553-8558
Number of pages6
JournalOrganic and Biomolecular Chemistry
Volume15
Issue number40
Publication statusPublished - 2017

Abstract

Carolacton, a secondary metabolite isolated from the extracts of Sorangium cellulosum, causes membrane damage and cell death in biofilms of the caries- and endocarditis-associated bacterium Streptococcus mutans and Streptococcus pneumoniae. It is known that macrolactam derivatives can show improved pharmacological properties compared to the corresponding macrolactons (lactam strategy). Therefore, we here report the total synthesis and biological activity of the lactam derivative of carolacton ("carolactam"). Carolactam was inactive against planktonic cultures of S. pneumoniae and caused damage of S. mutans biofilms at high concentrations only (above 10 μM). Preliminary modeling studies indicate substantial conformational differences between carolacton and carolactam.

ASJC Scopus subject areas

Cite this

The carolactam strategy is ineffective: Synthesis and biological evaluation of carolactam. / Ammermann, Jonas; Schmidt, Thomas; Donner, Jannik et al.
In: Organic and Biomolecular Chemistry, Vol. 15, No. 40, 2017, p. 8553-8558.

Research output: Contribution to journalArticleResearchpeer review

Ammermann, J, Schmidt, T, Donner, J, Reck, M, Dalton, M, Stumpp, N, Stiesch, M, Wagner-Döbler, I & Kirschning, A 2017, 'The carolactam strategy is ineffective: Synthesis and biological evaluation of carolactam', Organic and Biomolecular Chemistry, vol. 15, no. 40, pp. 8553-8558. https://doi.org/10.1039/c7ob02060k
Ammermann, J., Schmidt, T., Donner, J., Reck, M., Dalton, M., Stumpp, N., Stiesch, M., Wagner-Döbler, I., & Kirschning, A. (2017). The carolactam strategy is ineffective: Synthesis and biological evaluation of carolactam. Organic and Biomolecular Chemistry, 15(40), 8553-8558. https://doi.org/10.1039/c7ob02060k
Ammermann J, Schmidt T, Donner J, Reck M, Dalton M, Stumpp N et al. The carolactam strategy is ineffective: Synthesis and biological evaluation of carolactam. Organic and Biomolecular Chemistry. 2017;15(40):8553-8558. doi: 10.1039/c7ob02060k
Ammermann, Jonas ; Schmidt, Thomas ; Donner, Jannik et al. / The carolactam strategy is ineffective : Synthesis and biological evaluation of carolactam. In: Organic and Biomolecular Chemistry. 2017 ; Vol. 15, No. 40. pp. 8553-8558.
Download
@article{346b41c182dd40f69652ec152be90175,
title = "The carolactam strategy is ineffective: Synthesis and biological evaluation of carolactam",
abstract = "Carolacton, a secondary metabolite isolated from the extracts of Sorangium cellulosum, causes membrane damage and cell death in biofilms of the caries- and endocarditis-associated bacterium Streptococcus mutans and Streptococcus pneumoniae. It is known that macrolactam derivatives can show improved pharmacological properties compared to the corresponding macrolactons (lactam strategy). Therefore, we here report the total synthesis and biological activity of the lactam derivative of carolacton ({"}carolactam{"}). Carolactam was inactive against planktonic cultures of S. pneumoniae and caused damage of S. mutans biofilms at high concentrations only (above 10 μM). Preliminary modeling studies indicate substantial conformational differences between carolacton and carolactam.",
author = "Jonas Ammermann and Thomas Schmidt and Jannik Donner and Michael Reck and Marly Dalton and Nico Stumpp and Meike Stiesch and Irene Wagner-D{\"o}bler and Andreas Kirschning",
note = "Funding information: This work has been carried out as an integral part of the BIOFABRICATION FOR NIFE Initiative, which is financially supported by the ministry of Lower Saxony and the Volkswagen Stiftung (NIFE is the Lower Saxony Center for Biomedical Engineering, Implant Research and Development, a joint translational research center of the Hannover Medical School, the Leibniz University Hannover, the University of Veterinary Medicine Hannover and the Laser Center Hannover).",
year = "2017",
doi = "10.1039/c7ob02060k",
language = "English",
volume = "15",
pages = "8553--8558",
journal = "Organic and Biomolecular Chemistry",
issn = "1477-0520",
publisher = "Royal Society of Chemistry",
number = "40",

}

Download

TY - JOUR

T1 - The carolactam strategy is ineffective

T2 - Synthesis and biological evaluation of carolactam

AU - Ammermann, Jonas

AU - Schmidt, Thomas

AU - Donner, Jannik

AU - Reck, Michael

AU - Dalton, Marly

AU - Stumpp, Nico

AU - Stiesch, Meike

AU - Wagner-Döbler, Irene

AU - Kirschning, Andreas

N1 - Funding information: This work has been carried out as an integral part of the BIOFABRICATION FOR NIFE Initiative, which is financially supported by the ministry of Lower Saxony and the Volkswagen Stiftung (NIFE is the Lower Saxony Center for Biomedical Engineering, Implant Research and Development, a joint translational research center of the Hannover Medical School, the Leibniz University Hannover, the University of Veterinary Medicine Hannover and the Laser Center Hannover).

PY - 2017

Y1 - 2017

N2 - Carolacton, a secondary metabolite isolated from the extracts of Sorangium cellulosum, causes membrane damage and cell death in biofilms of the caries- and endocarditis-associated bacterium Streptococcus mutans and Streptococcus pneumoniae. It is known that macrolactam derivatives can show improved pharmacological properties compared to the corresponding macrolactons (lactam strategy). Therefore, we here report the total synthesis and biological activity of the lactam derivative of carolacton ("carolactam"). Carolactam was inactive against planktonic cultures of S. pneumoniae and caused damage of S. mutans biofilms at high concentrations only (above 10 μM). Preliminary modeling studies indicate substantial conformational differences between carolacton and carolactam.

AB - Carolacton, a secondary metabolite isolated from the extracts of Sorangium cellulosum, causes membrane damage and cell death in biofilms of the caries- and endocarditis-associated bacterium Streptococcus mutans and Streptococcus pneumoniae. It is known that macrolactam derivatives can show improved pharmacological properties compared to the corresponding macrolactons (lactam strategy). Therefore, we here report the total synthesis and biological activity of the lactam derivative of carolacton ("carolactam"). Carolactam was inactive against planktonic cultures of S. pneumoniae and caused damage of S. mutans biofilms at high concentrations only (above 10 μM). Preliminary modeling studies indicate substantial conformational differences between carolacton and carolactam.

UR - http://www.scopus.com/inward/record.url?scp=85031914197&partnerID=8YFLogxK

U2 - 10.1039/c7ob02060k

DO - 10.1039/c7ob02060k

M3 - Article

C2 - 28972613

AN - SCOPUS:85031914197

VL - 15

SP - 8553

EP - 8558

JO - Organic and Biomolecular Chemistry

JF - Organic and Biomolecular Chemistry

SN - 1477-0520

IS - 40

ER -

By the same author(s)